Navigating Today’s API Development Challenges

API development is becoming increasingly complex as discovery tools generate molecules that are potent but difficult to synthesize, scale, or formulate. In this Q&A, Kent Payne, Ph.D., Managing Director at Wilmington PharmaTech, discusses the challenges facing today’s small-molecule developers, from solid-state risks to route design and scale-up, and how early, expert intervention can prevent costly delays and keep promising therapies on a viable path to patients.